Pharmagreen Biotech Stock Price, News & Analysis
Company Description
Pharmagreen Biotech (OTC Link: PHBI) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $570.7K.
On a trailing twelve-month basis, Pharmagreen Biotech reported net income of -$876K.
This page provides a comprehensive overview of PHBI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Pharmagreen Biotech (PHBI) stock last traded at $0.0017, up 1.76% from the previous close. At a market capitalization of $570.7K, PHBI is classified as a micro-cap stock with approximately 691.3M shares outstanding.
Latest News
Pharmagreen Biotech has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include management, acquisition. View all PHBI news →
SEC Filings
Financial Highlights
operating income reached -$1.1M, and net income was -$876K. The company generated -$427K in operating cash flow. With a current ratio of 0.11, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Pharmagreen Biotech (PHBI) currently stands at 39.9 thousand shares, up 8.1% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 144.1%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Pharmagreen Biotech (PHBI) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
PHBI Company Profile & Sector Positioning
Pharmagreen Biotech (PHBI) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing PHBI often look at related companies in the same sector, including Gold River Prod (GRPS), Vibe Growth Corporation (VIBEF), Maple Leaf Green (MGWFF), Livewire (LVVV), and Nutra Pharma Corp (NPHC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PHBI's relative position within its industry.